Carlo Medici

Carlo Medici is chief executive officer of Alzeca Biosciences, Houston, USA, a company developing novel advanced imaging agents for the early diagnosis of neurodegenerative diseases, including Alzheimer’s disease.

Content by Carlo Medici:

Outside the Lab Clinical care

Better Biomarkers for AD R&D

09/13/2018 | Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality